select trial semaglutide nejm Oral and Cardiovascular Outcomes in Type 2 Diabetes Beyond obesity: Novo's SELECT re-defines

Metformin is an oral medication that is gaining some traction, but like Ozempic, it is only FDA-approved to treat type 2 diabetes

So xanomeline, which is under investigation, targets the M1 and M4 subtypes of the muscarinic and acetylcholine receptors in the brain (Foster et al., 2021

A seemingly suspicious queen jellyfish arrives at the scene

If you find yourself not losing weight on Mounjaro or a similar obesity medication during the first few weeks, it is crucial not to panic

Weight-loss injections like Ozempic and Mounjaro are increasingly popular, but their effects in menopause such as potential muscle and bone loss, changes in hormone therapy absorption, to name a few, demand thoughtful, evidence-led discussion

Wt: 4213.7 Inv